Next Article in Journal
PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays
Next Article in Special Issue
Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends
Previous Article in Journal
Prognostic Value of Affective Symptoms in First-Admission Psychotic Patients
Previous Article in Special Issue
Aquaporins and Brain Tumors
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessCommunication
Int. J. Mol. Sci. 2016, 17(7), 1041; doi:10.3390/ijms17071041

Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas

1
Department of Anatomical Pathology, Flinders University of South Australia, Bedford Park, South Australia 5042, Australia
2
Department of Surgical Pathology, SA Pathology at Flinders Medical Centre, Bedford Park, South Australia 5042, Australia
3
Medical Oncology, Flinders Medical Centre, Bedford Park, South Australia 5042, Australia
4
Asbestos Diseases Research Institute, Bernie Banton Centre, Concord Repatriation General Hospital, Concord 2139 Sydney, Australia
*
Author to whom correspondence should be addressed.
Academic Editor: Kenichi Ishibashi
Received: 25 May 2016 / Revised: 21 June 2016 / Accepted: 24 June 2016 / Published: 30 June 2016
(This article belongs to the Special Issue Aquaporin)
View Full-Text   |   Download PDF [347 KB, uploaded 30 June 2016]   |  

Abstract

(1) Background: Malignant mesothelioma (MM) is an aggressive tumour of the serosal membranes, associated with exposure to asbestos. Survival is generally poor, but prognostication for individual patients is difficult. We recently described Aquaporin 1 (AQP1) as independent prognostic factor in two separate retrospective cohorts of MM patients. Here we assess the usefulness of AQP1 prospectively, and determine the inter-observer agreement in assessing AQP1 scores; (2) Methods: A total of 104 consecutive cases of MM were included. Sufficient tissue for immunohistochemistry was available for 100 cases, and these cases were labelled for AQP1. Labelling was assessed by two pathologists. Complete clinical information and follow up was available for 91 cases; (3) Results: Labelling of ≥50% of tumour cells for AQP indicated improved prognosis in a univariate model (median survival 13 versus 8 months, p = 0.008), but the significance was decreased in a multivariate analysis. Scoring for AQP1 was robust, with an inter-observer kappa value of 0.722, indicating substantial agreement between observers; (4) Conclusion: AQP1 is a useful prognostic marker that can be easily incorporated in existing diagnostic immunohistochemical panels and which can be reliably interpreted by different pathologists. View Full-Text
Keywords: malignant mesothelioma; pleura; peritoneum; Aquaporin 1; asbestos; prognosis malignant mesothelioma; pleura; peritoneum; Aquaporin 1; asbestos; prognosis
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Driml, J.; Pulford, E.; Moffat, D.; Karapetis, C.; Kao, S.; Griggs, K.; Henderson, D.W.; Klebe, S. Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas. Int. J. Mol. Sci. 2016, 17, 1041.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top